OR WAIT null SECS
July 04, 2024
HCPs are major process-related impurities that must be monitored throughout biologics production for clearance.
June 14, 2024
Ecolab Life Sciences and Repligen have launched a new affinity resin, DurA Cycle, for large-scale biologics manufacturing.
June 13, 2024
Syngene's new production platform offers rapid protein synthesis with lower risk.
June 12, 2024
The completed expansion at AGC Biologics'Copenhagen, Denmark, site, doubles the company's single-use bioreactor capacity for mammalian-based services.
June 08, 2024
The biopharma industry is looking at continuous chromatography for sensitive molecules.
June 04, 2024
Pharm Tech Group looks at the challenges surrounding the development and manufacture of ATMPs in more detail with Agne Vaitkeviciene, CEO of Memel Biotech.
Pharm Tech Group chats with Dr. Monika Paulė, CEO and co-founder of Caszyme about the evolution of CRISPR.
May 30, 2024
A combination of rapid sterility methods with the industry standard compendial method should ensure maximum safety.
May 25, 2024
The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product.
May 20, 2024
The new facility will be the company’s first to offer full manufacturing processing for antibody drug conjugates.